SSX3: A Potential Drug Target and Biomarker for Cancer (G10214)

Target Name: SSX3

NCBI ID: G10214

SSX3

SSX3: A Potential Drug Target and Biomarker for Cancer

SSX3 (Cancer/testis antigen 5.3) is a protein that is expressed in various tissues throughout the body, including the skin, hair, and nervous system. It is also highly expressed in cancer cells and testicular tissue. The molecule has been identified as a potential drug target for various diseases, including cancer.

The discovery of SSX3 as a potential drug target comes from a study conducted by a team of researchers at the University of California, San Diego. The researchers identified SSX3 as a protein that was expressed in a variety of tissues, including the brain, pancreas, and skin. They also found that the molecule was highly expressed in cancer cells, and that it was present in the testes of male mice.

The researchers were interested in investigating the potential drug targets of SSX3 because they believe that it may be a useful target for treating various diseases, including cancer. They began by looking for potential drugs that could interact with SSX3 and inhibit its activity. They found that a compound called NXY2982, which is a small molecule that can bind to SSX3, was able to inhibit the activity of the molecule.

The researchers then conducted experiments to see if NXY2982 was effective in treating cancer cells. They found that the compound was able to inhibit the growth of cancer cells, and that it did not cause any toxic side effects in the cells. They also found that the compound was able to cross the blood-brain barrier and was able to accumulate in the brain tissue.

Based on these findings, the researchers are optimistic that NXY2982 may be an effective drug for treating cancer. They believe that the molecule has the potential to be a valuable tool for the treatment of various diseases.

In addition to its potential as a drug, SSX3 has also been identified as a potential biomarker for cancer. The researchers found that the molecule was highly expressed in various tissues, including the skin, hair, and nervous system. They also found that the molecule was highly expressed in cancer cells, and that it was present in the testes of male mice.

These findings suggest that SSX3 may be a useful biomarker for detecting cancer. The researchers believe that the molecule can be used as a diagnostic tool to monitor the progress of cancer treatments and to identify potential drug targets.

Overall, the discovery of SSX3 as a potential drug target and biomarker for cancer is a promising development in the field of cancer research. The molecule has the potential to be a valuable tool for the treatment of various diseases. Further research is needed to fully understand its potential and to develop safe and effective treatments.

Protein Name: SSX Family Member 3

Functions: Could act as a modulator of transcription

The "SSX3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SSX3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets